Clinical Trials for EGFR Positive Non-small Cell Lung Cancer

Find clinical trials for egfr positive non-small cell lung cancer. Discover research opportunities and treatment options in your area.

6 Active Trials Found

Showing 6 trials on this page

Page 1 of 1

A Study of APG-1252 Plus Osimertinib(AZD9291) in EGFR TKI Resistant NSCLC Patients

NCT ID: NCT04001777

This clinical trial is investigating a new treatment approach for patients with a type of lung cancer called EGFR positive non-small cell lung cancer (NSCLC) who have not responded to standard ther...

Recruiting

Phase: PHASE1 Type: interventional Locations: Zhengzhou, Henan, China, Chang Chun, Jilin, China +3 more

Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study

NCT ID: NCT05089916

This clinical trial is studying how safe and effective it is to continue a medication called osimertinib while patients receive radiation therapy for a type of lung cancer known as non-small cell l...

Recruiting

Phase: PHASE2 Type: interventional Locations: München, , Germany

Patient-centered, Optimal Integration of Survivorship and Palliative Care

NCT ID: NCT04900935

This clinical trial is studying a new supportive care program called POISE for patients with advanced Non-small Cell Lung Cancer (NSCLC). The main goal is to see if this program can help patients f...

Recruiting

Phase: NA Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States

SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)

NCT ID: NCT06208033

This clinical trial is studying a new treatment for patients with advanced non-small cell lung cancer (NSCLC) who have a specific genetic marker called EGFR. The trial looks at how well two drugs, ...

Not yet recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Fuzhou, , China

A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy

NCT ID: NCT05338619

This clinical trial is studying a medication called Lazertinib to see if it can help patients with locally advanced, unresectable non-small cell lung cancer (NSCLC) who have an EGFR mutation after ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Incheon, , Korea, Republic Of, Seoul, , Korea, Republic Of +13 more

Neoadjuvant Toripalimab for Non-squamous NSCLC With EGFR Mutation

NCT ID: NCT05962021

This clinical trial is looking at a new treatment approach for patients with a specific type of lung cancer called non-squamous non-small cell lung cancer (NSCLC) that has a mutation in the EGFR ge...

Not yet recruiting

Phase: PHASE2 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions